These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7952)

  • 21. Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial.
    Abrams J; Allen J; Allin D; Anderson J; Anderson S; Blanski L; Chadda K; DiBianco R; Favrot L; Gonzalez J
    Am Heart J; 1985 Nov; 110(5):913-22. PubMed ID: 3904379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic effects of tolamolol on atrioventricular conduction in man.
    Ruskin JN; Caracta AR; Akhtar M; Batsford WP; Damato AN
    Am Heart J; 1975 Dec; 90(6):755-66. PubMed ID: 1242869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W
    Arzneimittelforschung; 1983; 33(2a):339-45. PubMed ID: 6682327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Esmolol: a novel cardioselective, titratable, intravenous beta-blocker with ultrashort half-life.
    Covinsky JO
    Drug Intell Clin Pharm; 1987 Apr; 21(4):316-21. PubMed ID: 2882993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardioselective beta receptor blockade in acute myocardial infarct with talinolol].
    Assmann I; Fiehring H; Oltmanns G; Kulick B; Kretzschmar E
    Z Gesamte Inn Med; 1981 Sep; 36(18):637-44. PubMed ID: 6118980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blocking therapy in atrial and ventricular tachyarrhythmias: experience with nadolol.
    Coumel P; Escoubet B; Attuel P
    Am Heart J; 1984 Oct; 108(4 Pt 2):1098-108. PubMed ID: 6148870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arrhythmia in hypertrophic cardiomyopathy: exercise and 48 hour ambulatory electrocardiographic assessment with and without beta adrenergic blocking therapy.
    McKenna WJ; Chetty S; Oakley CM; Goodwin JF
    Am J Cardiol; 1980 Jan; 45(1):1-5. PubMed ID: 6101296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias.
    Balser JR; Martinez EA; Winters BD; Perdue PW; Clarke AW; Huang W; Tomaselli GF; Dorman T; Campbell K; Lipsett P; Breslow MJ; Rosenfeld BA
    Anesthesiology; 1998 Nov; 89(5):1052-9. PubMed ID: 9821992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation.
    Atwood JE; Sullivan M; Forbes S; Myers J; Pewen W; Olson HG; Froelicher VF
    J Am Coll Cardiol; 1987 Aug; 10(2):314-20. PubMed ID: 2885354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effects of tolamolol on excito-conduction in men (author's transl)].
    Alboni P; Malacarne C; Tomasi AM; Masoni A
    G Ital Cardiol; 1977; 7(9):862-9. PubMed ID: 336446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical evaluation of bisoprolol in the treatment of extrasystoles and sinus tachycardia: an interim report.
    Sugimoto T; Hayakawa H; Osada H; Yamazaki N; Mori H; Yasuda H; Sakamoto A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S171-4. PubMed ID: 2439792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics and therapeutic efficacy of esmolol.
    Wiest DB; Haney JS
    Clin Pharmacokinet; 2012 Jun; 51(6):347-56. PubMed ID: 22515557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
    Allen JD; Shanks RG
    Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effective treatment of supraventricular arrhythmias with acebutolol.
    Williams DO; Tatelbaum R; Most AS
    Am J Cardiol; 1979 Sep; 44(3):521-5. PubMed ID: 382821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous esmolol for the treatment of supraventricular tachyarrhythmia: results of a multicenter, baseline-controlled safety and efficacy study in 160 patients. The Esmolol Research Group.
    Am Heart J; 1986 Sep; 112(3):498-505. PubMed ID: 2875641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiology of beta blockers in supraventricular arrhythmias.
    Kowey PR; Friehling TD; Marinchak RA
    Am J Cardiol; 1987 Aug; 60(6):32D-38D. PubMed ID: 2888299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Properties of acebutolol in twenty patients with cardiac arrhythmias.
    Biron P; Proulx A; Lapointe L; Nadeau R; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):11-4. PubMed ID: 1233201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Propafenon, a new antiarrhythmic agent for the treatment of ectopic and rapid cardiac arrhythmias (author's transl)].
    Beck OA
    Med Klin; 1975 Jan; 70(3-2):95-101. PubMed ID: 48183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined use of esmolol and digoxin in the acute treatment of atrial fibrillation or flutter.
    Shettigar UR; Toole JG; Appunn DO
    Am Heart J; 1993 Aug; 126(2):368-74. PubMed ID: 8101692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.